Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1Phase 4 1Phase 2 1Phase 1 1

Status

Active not recruiting 4Completed 2

Sponsor Class

OTHER 2INDUSTRY 2NIH 1NETWORK 1

Study Type

Interventional 6

Sponsor

Cancer Type

Genitourinary 6

Conditions

Prostatic Neoplasms 5Neoplasm Metastasis 1Hormone Sensitive Prostate Cancer 1

Interventions

Specimen Handling 67Magnetic Resonance Spectroscopy 54Biopsy 43pembrolizumab 35Carboplatin 32Nivolumab 30Radiotherapy 26Cyclophosphamide 26Cisplatin 26Radiation 25Paclitaxel 25olaparib 19Etoposide 18Taxes 17Radiotherapy, Intensity-Modulated 17Dexamethasone 17durvalumab 16Doxorubicin 16Disulfides 16Bevacizumab 16X-Rays 15Immunoglobulin G 15Platinum 14Docetaxel 14Cytarabine 14Vincristine 13Prednisone 13Pemetrexed 13Leucovorin 13Lenalidomide 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Has results × Androgen Antagonists × 30 days × Clear all
NCT03388619 2026-05-27

Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
30 enrolled 16 charts
Genitourinary

Prostatic Neoplasms

NCT04126070 2026-05-27

Nivolumab + Docetaxel + ADT in mHSPC Patients With DDRD or Inflamed Tumors

Dana-Farber Cancer Institute

Phase 2 Active not recruiting
47 enrolled 16 charts
Genitourinary

Hormone Sensitive Prostate Cancer

NCT03644303 2026-05-14

TRAP

Royal Marsden NHS Foundation Trust

Phase NA Completed
86 enrolled 27 charts
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT02489318 2026-05-11

TITAN

Aragon Pharmaceuticals, Inc.

Phase 3 Active not recruiting
1,052 enrolled 13 charts 1 FDA
Genitourinary

Prostatic Neoplasms

NCT04108208 2026-05-11

A Study of Apalutamide in Chinese Participants With Non Metastatic Castration Resistant Prostate Cancer (NM-CRPC)

Janssen Research & Development, LLC

Phase 4 Active not recruiting
75 enrolled 9 charts
Genitourinary

Prostatic Neoplasms

NCT01368588 2026-05-08

Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer

Radiation Therapy Oncology Group

Phase 3 Active not recruiting
2,590 enrolled 18 charts
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡